We provide you with 20 years of free, institutional-grade data for ALLO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALLO. Explore the full financial landscape of ALLO stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| MESSEMER DEBORAH M. | Sale | -36,885 | $1.42 | $52,377 | 2025-06-12 |
| Yoshiyama Annie | Sale | -9,601 | $1.41 | $13,537 | 2025-04-23 |
| Beneski Benjamin Machinas | Sale | -5,488 | $1.98 | $10,839 | 2025-03-18 |
| Chang David D | Sale | -46,668 | $1.96 | $91,469 | 2025-03-18 |
| Beneski Benjamin Machinas | Grant, award...etc | 31,755 | 2025-03-05 | ||
| Beneski Benjamin Machinas | Initial | 2025-03-04 | |||
| MESSEMER DEBORAH M. | Sale | -13,313 | $2.43 | $32,351 | 2025-02-20 |
| Roberts Zachary | Sale | -18,832 | $1.7 | $32,014 | 2025-02-05 |
| MOORE TIMOTHY L. | Sale | -14,746 | $1.71 | $25,216 | 2025-02-05 |
| Parker Geoffrey M. | Sale | -4,361 | $1.73 | $7,545 | 2025-02-05 |
| Douglas Earl Martin | Sale | -6,404 | $1.71 | $10,951 | 2025-02-05 |
| Chang David D | Sale | -46,003 | $1.68 | $77,285 | 2025-02-05 |
| Belldegrun Arie | Grant, award...etc | 369,957 | 2025-01-28 | ||
| Chang David D | Grant, award...etc | 552,174 | 2025-01-28 | ||
| Roberts Zachary | Grant, award...etc | 173,913 | 2025-01-28 | ||
| Douglas Earl Martin | Grant, award...etc | 144,928 | 2025-01-28 | ||
| Yoshiyama Annie | Grant, award...etc | 36,232 | 2025-01-28 | ||
| Parker Geoffrey M. | Grant, award...etc | 173,913 | 2025-01-28 | ||
| Roberts Zachary | Sale | -27,199 | $1.78 | $48,414 | 2025-01-23 |
| MESSEMER DEBORAH M. | Sale | -9,136 | $2.18 | $19,916 | 2024-12-10 |
| Humer Franz B | Sale | -9,221 | $2.16 | $19,917 | 2024-12-09 |
| Parker Geoffrey M. | Sale | -36,404 | $2.84 | $103,387 | 2024-10-23 |
| Douglas Earl Martin | Sale | -28,310 | $2.79 | $78,843 | 2024-08-23 |
| MESSEMER DEBORAH M. | Sale | -18,641 | $2.28 | $42,488 | 2024-06-20 |
| Yoshiyama Annie | Initial | 2024-06-11 | |||
| SATO VICKI L | Grant, award...etc | 61,475 | 2024-06-07 | ||
| Humer Franz B | Grant, award...etc | 61,475 | 2024-06-07 | ||
| MESSEMER DEBORAH M. | Grant, award...etc | 122,950 | 2024-06-07 | ||
| Humer Franz B | Sale | -11,200 | $2.34 | $26,181 | 2024-06-03 |
| Parker Geoffrey M. | Grant, award...etc | 344,828 | $2.9 | 2024-05-20 | |
| Belldegrun Arie | Open Market Purchase | 1,724,137 | $2.9 | 2024-05-20 | |
| Belldegrun Arie | Grant, award...etc | 344,828 | $2.9 | 2024-05-20 | |
| Chang David D | Grant, award...etc | 344,828 | $2.9 | 2024-05-20 | |
| MOORE TIMOTHY L. | Sale | -17,360 | $3.47 | $60,189 | 2024-04-24 |
| Chang David D | Sale | -53,393 | $4.33 | $231,192 | 2024-03-18 |
| Parker Geoffrey M. | Open Market Purchase | 190 | $3.6 | 2024-03-06 | |
| Roberts Zachary | Grant, award...etc | 140,000 | 2024-01-31 | ||
| Chang David D | Grant, award...etc | 317,800 | 2024-01-31 | ||
| MOORE TIMOTHY L. | Grant, award...etc | 96,600 | 2024-01-31 | ||
| Parker Geoffrey M. | Grant, award...etc | 29,400 | 2024-01-31 | ||
| Douglas Earl Martin | Grant, award...etc | 41,800 | 2024-01-31 | ||
| Belldegrun Arie | Grant, award...etc | 211,973 | 2024-01-31 | ||
| Roberts Zachary | Sale | -24,690 | $3.17 | $78,376 | 2024-01-24 |
| MESSEMER DEBORAH M. | Sale | -18,640 | $2.7 | $50,317 | 2023-12-20 |
| Parker Geoffrey M. | Grant, award...etc | 790,000 | 2023-10-17 | ||
| Douglas Earl Martin | Grant, award...etc | 435,834 | 2023-08-17 | ||
| CHEN YINLIN JACK | Grant, award...etc | 11,401 | 2023-08-14 | ||
| CHEN YINLIN JACK | Initial | 2023-08-14 | |||
| Mayo Stephen | Sale | -10,000 | $4.29 | $42,855 | 2023-08-09 |
| SATO VICKI L | Grant, award...etc | 59,649 | 2023-06-15 | ||
| Humer Franz B | Grant, award...etc | 74,561 | 2023-06-15 | ||
| WITTE OWEN N. | Grant, award...etc | 74,561 | 2023-06-15 | ||
| MESSEMER DEBORAH M. | Grant, award...etc | 74,561 | 2023-06-15 | ||
| MOORE TIMOTHY L. | Grant, award...etc | 186,219 | 2023-04-26 | ||
| Smith Lillian | Initial | 2023-04-05 | |||
| Smith Lillian | Grant, award...etc | 56,545 | 2023-04-05 | ||
| MOORE ALISON | Grant, award...etc | 558,094 | 2023-03-24 | ||
| SCHMIDT ERIC THOMAS | Grant, award...etc | 558,094 | 2023-03-24 | ||
| Roberts Zachary | Grant, award...etc | 148,035 | 2023-03-24 | ||
| Belldegrun Arie | Grant, award...etc | 1,282,976 | 2023-03-24 | ||
| Chang David D | Grant, award...etc | 1,924,464 | 2023-03-24 | ||
| Chang David D | Sale | -22,340 | $5.56 | $124,210 | 2023-03-16 |
| SCHMIDT ERIC THOMAS | Sale | -35,879 | $5.47 | $196,258 | 2023-03-16 |
| MOORE ALISON | Sale | -8,351 | $5.51 | $45,990 | 2023-03-16 |
| Bhavnagri Veer | Sale | -23,628 | $5.67 | $133,971 | 2023-03-16 |
| Bhavnagri Veer | Sale | -3,000 | $6.85 | $20,550 | 2023-02-14 |
The information provided in this report about ALLO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Allogene Therapeutics, Inc(NASDAQ:ALLO) 
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candi...
Website: http://www.allogene.com
Founded: 2017
Full Time Employees: 264
Sector: Healthcare
Industry: Biotechnology